EMSAM (deprenyl patch): how a promising antidepressant was underutilized

References

• RushAJTrivediMHWisniewskiSRAcute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D reportAm J Psychiatry2006163111905191717074942
   PubMed Web of Science ®Google Scholar
• RooseSPCompliance: the impact of adverse events and tolerability on the physician’s treatment decisionsEur Neuropsychopharmacol200313Suppl 3S85S9214550581
   PubMed Web of Science ®Google Scholar
• TrivediMHRushAJWisniewskiSREvaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practiceAm J Psychiatry20061631284016390886
   PubMed Web of Science ®Google Scholar
• JakubovskiEBlochMHPrognostic subgroups for citalopram response in the STAR*D trialJ Clin Psychiatry201475773874724912106
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationPractice guidelines for the treatment of patients with major depressive disorder (Revision)Am J Psychiatry2000157Suppl 4145
   Web of Science ®Google Scholar
• American Psychiatric AssociationPractice guidelines for the treatment of patients with major depressive disorder (Third Edition)Am J Psychiatry2010167Suppl111820068118
   PubMed Web of Science ®Google Scholar
• MuramatsuRSLitzingerMHFisherETakeshitaJAlternative formulations, delivery methods, and administration options for psychotropic medications in elderly patients with behavioral and psychological symptoms of dementiaAm J Geriatr Pharmacother2010829811420439060
   PubMedGoogle Scholar
• MoukaddamNJHirschfeldRMIntravenous antidepressants: a reviewDepress Anxiety20041911914978779
   PubMed Web of Science ®Google Scholar
• AzzaroAJZiemniakJKemperECampbellBJVandenbergCPharmacokinetics and absolute bioavailability of selegiline following treatment of healthy subjects with the selegiline transdermal system (6 mg/24 h): a comparison with oral selegiline capsulesJ Clin Pharmacol200747101256126717715422
   PubMed Web of Science ®Google Scholar
• RobinsonDSAmsterdamJDThe selegiline transdermal system in major depressive disorder: a systematic review of safety and tolerabilityJ Affect Disord20081051–3152317568687
   PubMed Web of Science ®Google Scholar
• BodkinJAAmsterdamJDTransdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatientsAm J Psychiatry2002159111869187512411221
   PubMed Web of Science ®Google Scholar
• AmsterdamJDA double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorderJ Clin Psychiatry200364220821412633131
   PubMed Web of Science ®Google Scholar
• FeigerADRickelsKRynnMAZimbroffDLRobinsonDSSelegiline trandermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trialJ Clin Psychiatry20066791354136117017821
   PubMed Web of Science ®Google Scholar
• AmsterdamJDBodkinJASelegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trialJ Clin Psychopharmacol200626657958617110814
   PubMed Web of Science ®Google Scholar
• Lopez-MunozFAlamoCJuckelGAssionHJHalf a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part I: monoamine oxidase inhibitorsJ Clin Psychopharmacol200727655555918004120
   PubMed Web of Science ®Google Scholar
• QuitkinFMStewartJWMcGrathPJColumbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placeboBr J Psychiatry Suppl19932130348217065
   PubMedGoogle Scholar
• HenkelVMerglRAllgaierAKKohnenRMöllerHJHegerlUTreatment of depression with atypical features: a meta-analytic approachPsychiatry Res200614118910116321446
   PubMed Web of Science ®Google Scholar
• McGrathPJStewartJWHarrisonWWagerSQuitkinFMPhenelzine treatment of melancholiaJ Clin Psychiatry19864784204223525522
   PubMed Web of Science ®Google Scholar
• McGrathPJStewartJWJanalMNPetkovaEQuitkinFMKleinDFA placebo-controlled study of fluoxetine versus imipramine in the treatment of atypical depressionAm J Psychiatry2000157334435010698808
   PubMed Web of Science ®Google Scholar
• McGrathPJStewartJWFavaMTranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D reportAm J Psychiatry200616391531154116946177
   PubMed Web of Science ®Google Scholar
• SunderlandTCohenRMMolchanSHigh-dose selegiline in treatment-resistant older depressive patientsArch Gen Psychiatry19945186076157519005
   PubMed Web of Science ®Google Scholar
• MorganPTTreatment-resistant depression: response to low-dose transdermal but not oral selegilineJ Clin Psychopharmacol200727331331417502787
   PubMed Web of Science ®Google Scholar
• AshtonAKA case report of high-dose transdermal selegiline in the treatment of major depressive disorderAnn Clin Psychiatry2009211515219239833
   PubMed Web of Science ®Google Scholar
• KrishnanKRRevisiting monoamine oxidase inhibitorsJ Clin Psychiatry200768Suppl 8354117640156
   PubMed Web of Science ®Google Scholar
• GhaemiSNHsuDJSoldaniFGoodwinFKBipolar DisordAnidepressants in bipolar disorder: the case for caution200356421433
   PubMed Web of Science ®Google Scholar
• ClaryCMandosLSchweitzerEResults of a brief survey of the prescribing practices for monoamine oxidase inhibitor antidepressantsJ Clin Psychiatry19905162262312347859
   PubMed Web of Science ®Google Scholar
• BalonRMuftiRArfkenCLA survey of prescribing practices for monoamine oxidase inhibitorsPsychiatric Services199950794594710402617
   PubMed Web of Science ®Google Scholar
• ShulmanKIWalkerSERefining the MAOI diet: tyramine content of pizzas and soy productsJ Clin Psychiatry199960319119310192596
   PubMed Web of Science ®Google Scholar
• AndersonIMFerrierINBaldwinRCEvidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guideinesJ Psychopharmacol200822434339618413657
   PubMed Web of Science ®Google Scholar
• LamRWKennedySHGrigoriadisSCanadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults, pt 3: PharmacotherapyJ Affect Disord2009117Suppl 1S26S4319674794
   PubMed Web of Science ®Google Scholar
• CascadeEFKalaliAHPreskornSHEMSAM: The first yearPsychiatry (Edgmont)200746192120711332
   PubMedGoogle Scholar
• CooperAJTyramine and irreversible monoamine oxidase inhibitors in clinical practiceBr J Psychiatry19896Suppl3845
   Web of Science ®Google Scholar
• HendleyEDSnyderSHThe relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacyNature19682205174133013315701350
   PubMed Web of Science ®Google Scholar
• HorwitzDLovenbergWEngelmanKSjoerdsmaAMonoamine oxidase inhibitors, tyramine, and cheeseJAMA19641881108111014163106
   PubMed Web of Science ®Google Scholar
• AsatoorAMLeviAJMilneMDTranylcypromine and cheeseLancet19632731073314057166
   PubMed Web of Science ®Google Scholar
• StahlSMStahl’s Essential Psychopharmacology: Neuroscientific Basic and Practical Applications4th edNew YorkCambridge University Press2013
   Google Scholar
• PaeCUBodkinJAPortlandKBThaseMEPatkarAASafety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposuresJ Clin Psychiatry201273566166822697192
   PubMed Web of Science ®Google Scholar
• WalkerSEShulmasKITailorSRGardnerDTyramine content of previously restricted foods in monoamine oxidase inhibitor dietsJ Clin Psychopharmacol19961653833888889911
   PubMed Web of Science ®Google Scholar
• SternbachHThe serotonin syndromeAm J Psychiatry199114867057132035713
   PubMed Web of Science ®Google Scholar
• KramerMSleep loss in resident physicians: the cause of medical errors?Front Neurol2010112811021188247
   PubMedGoogle Scholar
• JacobJEWagnerMLSageJISafety of selegiline with cold medicationsAnn Pharmacother200337343844112639177
   PubMed Web of Science ®Google Scholar
• KesslerRCBerglundPDemlerOThe epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)JAMA2003289233095310512813115
   PubMed Web of Science ®Google Scholar
• RavindranLNSteinMBPharmacotherapy of post-traumatic stress disorderCurr Top Behav Neurosci2010250552521309124
   PubMedGoogle Scholar
• SinclairLIChristmasDMSeanDAntidepressant-induced jitteriness/anxiety syndrome: systematic reviewBr J Psychiatry2009194648349019478285
   PubMed Web of Science ®Google Scholar
• CiprianiAFurukawaTASalantiGComparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta analysisLancet2009373966574675819185342
   PubMed Web of Science ®Google Scholar
• StahlSMEnhancing outcomes from major depression: using antidepressant combination therapies with multifunctional pharmacologic mechanisms from the initiation of treatmentCNS Spectr2010152799420414154
   PubMed Web of Science ®Google Scholar
• WimbiscusMKostenkoOMaloneDMAO inhibitors: risks, benefits, and loreCleve Clin J Med2010771285988221147941
   PubMed Web of Science ®Google Scholar
• ChenYKeltonCMJingYGuoJJLiXPatelNCUtilization, price, and spending trends for antidepressants in the US Medicaid programRes Social Adm Pharm20084324425718794035
   PubMed Web of Science ®Google Scholar
• SoutulloCFigueroa-QuintanaAWhen do you prescribe antidepressants to depressed children?Curr Psychiatry Rep201315736623712717
   PubMed Web of Science ®Google Scholar
• MeyersBSJesteDVGeriatric psychopharmacology: evolution of a disciplineJ Clin Psychiatry201071111416142421114947
   PubMed Web of Science ®Google Scholar
• BridgeJABirmaherBIyengarSBarbeRPBrentDAPlacebo response in randomized controlled trials of antidepressants for pediatric major depressive disorderAm J Psychiatry20091661424919047322
   PubMed Web of Science ®Google Scholar
• ReynoldsCF3rdFrankEKupferDJTreatment outcome in recurrent major depression: A post hoc comparison of elderly (“young old”) and midlife patientsAm J Psychiatry199615310128812928831436
   PubMed Web of Science ®Google Scholar
• CheungAHEmslieGJMayesTLThe use of antidepressants to treat depression in children and adolescentsCMAJ2006174219320016415467
   PubMed Web of Science ®Google Scholar
• SlotkinTASeidlerFJRitchieJCRegional differences in brain monoamine oxidase subtypes in an animal model of geriatric depression: effects of olfactory bulbectomy in young versus aged ratsBrain Res20008821–214915411056194
   PubMed Web of Science ®Google Scholar
• MeyerJHGinovartNBoovariwalaAElevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depressionArch Gen Psychiatry200663111209121617088501
   PubMed Web of Science ®Google Scholar
• SlotkinTAWhitmoreWLBarnesGAReduced inhibitory effect of imipramine on radiolabeled serotonin uptake into platelets in geriatric depressionBiol Psychiatry19892566876912538161
   PubMed Web of Science ®Google Scholar
• DelBelloMPHochadelTJPortlandKBA double-blind, placebo-controlled study of selegiline transdermal system in depressed adolescentsJ Child Adolesc Psychopharmacol201424631131724955812
   PubMed Web of Science ®Google Scholar
• KupferDJThe pharmacological management of depressionDialogues Clin Neurosci20057319120516156378
   PubMedGoogle Scholar
• HansenDLTuliniusDHansenEHAdolescents’ struggles with swallowing tablets: barriers, strategies and learningPharm World Sci2008301656917594531
   PubMedGoogle Scholar
• WrightDMedication administration in nursing homesNurs Stand20021642333812216309
   PubMedGoogle Scholar
• AsbergMTreatment of depression with tricyclic drugs-pharmacokinetic and pharmacodynamic aspectsPharmakopsychiatr Neuropsychopharmakol197691182610583
   PubMedGoogle Scholar
• AsnisGMFriedmanTASandersonWCKaplanMLvan PraagHMHarkavy-FriedmanJMSuicidal behaviors in adult psychiatric outpatients, I: Description and prevalenceAm J Psychiatry199315011081128417551
   PubMed Web of Science ®Google Scholar
• EMSAM [package insert]Napa, CADey Pharma2009
   Google Scholar
• WiesbrockUORocholzGFranzeliusCSchwarkTGrellnerWExcessive use of fentanyl patches as the only means of suicideArch Kriminol20082221–2233018780718
   PubMedGoogle Scholar
• LovecchioFRamosLSuicide by Duragesic transdermal fentanyl patch toxicityAm J Emerg Med201029113120825866
   PubMed Web of Science ®Google Scholar
• RaberJHShinarCFinkelsteinSClonidine patch ingestion in an adultAnn Pharmacother19932767197228329790
   PubMed Web of Science ®Google Scholar
• WoolfABurkhartKCaraccioTLitovitzTSelf-poisoning among adults using multiple transdermal nicotine patchesJ Toxicol Clin Toxicol19963466916988941198
   PubMed Web of Science ®Google Scholar
• AngstJAzorinJMBowdenCLPrevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE studyArch Gen Psychiatry201168879179821810644
   PubMed Web of Science ®Google Scholar
• TondoLVazquezGBaldessariniRJMania associated with antidepressant treatment: comprehensive meta-analytic reviewActa Psychiatr Scand2010121640441419958306
   PubMed Web of Science ®Google Scholar
• FavaMRushAJAlpertJEDifference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D reportAm J Psychiatry2008165334235118172020
   PubMed Web of Science ®Google Scholar
• PapakostasGIStahlSMKrishenAEfficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studiesJ Clin Psychiatry20086981287129218605812
   PubMed Web of Science ®Google Scholar
• KleinDFLiebowitzMRHysteroid dysphoriaAm J Psychiatry198213911152015217137409
   PubMed Web of Science ®Google Scholar
• RobinsonDPortlandKBSelegiline transdermal system (STS) for anxious depression: A post hoc analysis of 3 randomized, placebo-controlled, double-blind studiesPresented at the Annual Meeting of the American Psychiatric AssociationMay 15, 2011Honolulu, Hawaii
   Google Scholar
• AsnisGMMcGinnLKSandersonWCAtypical depression: clinical aspects and noradrenergic functionAm J Psychiatry1995152131367802117
   PubMed Web of Science ®Google Scholar
• StewartJWMcGrathPJFavaMDo atypical features affect outcome in depressed outpatients treated with citalopram?Int J Neuropsychopharmacol2010131153019341509
   PubMed Web of Science ®Google Scholar
• PaeCUPatkarAAJangSPortlandKBJungSNelsonJCEfficacy and safety of selegiline transdermal system (STS) for the atypical subtype of major depressive disorder: pooled analysis of 5 short-term, placebo-controlled trialsCNS Spectr20132916
   Google Scholar